Abstract
Common variable Immunodeficiency (CVID) is a heterogeneous primary Immunodeficiency disease. Immunoglobulin A Deficiency (IGAD) shares some clinical, laboratory, and genetic features with CVID and occurs with relatively greater frequency in first-degree relatives of individuals with CVID. Recently, patients with CVID and IGAD have been found to have mutations of the gene TNFRSF13B encoding the TACI (transmembrane activator and calcium-modulator and cyclophilin-ligand interactor), a member of the tumor necrosis factor-receptor superfamily. In this article, we review the various TACI mutations that have been identified so far. Although six mutations have been reported, no clear genotype-phenotype association has been shown to date. This suggests that the phenotypic expression of TACI mutation is affected by additional genetic and environmental factors. Analysis of a larger sample of patients will be needed to determine if the specific mutations are associated with a particular phenotype or predisposition to the common features of CVID and IGAD: autoimmunity, lymphoproliferation, or malignancy.
Similar content being viewed by others
References and Recommended Reading
Cunningham-Rundles C: Clinical and immunologic analysis of 103 patients with common variable immunode.-ciency. J Clin Immunol 1989, 9:22–23.
Cunningham-Rundles C, Bodian C: Common variable Immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 2:34–48.
Hammarstrom L, Vorechovsky I, Webster D: Selective IgA Deficiency (SIgAD) and common variable Immunodeficiency (CVID). Clin Exp Immunol 2000, 120:225–231.
Ochs H, Winkelstein J: Disorders of the B-cell system. In Immunologic Disorders in Infants and Children. Edited by Stiehm R. Philadelphia: WB Saunders; 1996:296–338.
Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, et al.: Incidence of cancer in 98 patients with common varied Immunodeficiency. J Clin Immunol 1987, 7:294–299.
Majolini MB, D’Elios MM, Boncristiano M, et al.: Uncoupling of T-cell antigen receptor and downstream protein tyrosine kinases in common variable Immunodeficiency. Clin Immunol Immunopathol 1997, 84:98–102.
Ferrer JM, Iglesias J, Hernandez M, et al.: Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable Immunodeficiency (CVI) patients. Clin Exp Immunol 1995, 102:286–289.
Warnatz K, Denz A, Drager R, et al.: Severe Deficiency of switched memory B cells (CD27(+)IgM(•)IgD(•)) in subgroups of patients with common variable immunode.-ciency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544–1551.
Andersen P, Permin H, Andersen V, et al.: Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable Immunodeficiency. Blood 2005, 105:511–517.
Inoue Y, Kondo N, Motoyoshi F, et al.: Abnormal responses of common variable Immunodeficiency patients’ B cells to Staphylococcus aureus Cowan I and interleukin-2. Acta Paediatr 1993, 82:404–407.
Cunningham-Rundles C, Radigan L, Knight AK, et al.: TLR9 activation is defective in common variable immune Deficiency. J Immunol 2006, 176:1978–1987.
Farrington M, Grosmaire LS, Nonoyama S, et al.: CD40 ligand expression is defective in a subset of patients with common variable Immunodeficiency. Proc Natl Acad Sci U S A 1994, 91:1099–1103.
Cunningham-Rundles C: Disorders of the IgA system. In Immunologic Disorders in Infants and Children. Edited by Stiehm R. Philadelphia: WB Saunders; 1996:423–442.
Ashman RF, Schaffer FM, Kemp JD, et al.: Genetic and immunologic analysis of a family containing five patients with common-variable immune Deficiency or selective IgA Deficiency. J Clin Immunol 1992, 12:406–414.
Rosner F, Vallejo V, Khan FA, et al.: Hypogammaglobulinemia and selective immunoglobulin A Deficiency. Double consanguinity in family. N Y State J Med 1978, 78:1459–1463.
Espanol T, Catala M, Hernandez M, et al.: Development of a common variable Immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 1996, 80:333–335.
Weston SA, Prasad ML, Mullighan CG, et al.: Assessment of male CVID patients for mutations in the Btk gene: How many have been misdiagnosed? Clin Exp Immunol 2001, 124:465–469.
Eastwood D, Gilmour KC, Nistala K, et al.: Prevalence of SAP gene defects in male patients diagnosed with common variable Immunodeficiency. Clin Exp Immunol 2004, 137:584–588.
Nistala K, Gilmour KC, Cranston T, et al.: X-linked lymphoproliferative disease: three atypical cases. Clin Exp Immunol 2001, 126:126–130.
Grimbacher B, Hutloff A, Schlesier M, et al.: Homozygous loss of ICOS is associated with adult-onset common variable Immunodeficiency. Nat Immunol 2003, 4:261–268.
Salzer U, Maul-Pavicic A, Cunningham-Rundles C, et al.: ICOS Deficiency in patients with common variable immunode ficiency. Clin Immunol 2004, 113:234–240.
Kralovicova J, Hammarstrom L, Plebani A, et al.: Finescale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA Deficiency and common variable Immunodeficiency. J Immunol 2003, 170:2765–2775.
De la Concha EG, Fernandez-Arquero M, Gual L: MHC susceptibility genes to IgA Deficiency are located in different regions on different HLA haplotypes. J Immunol. 2002, 169:4637–43.
Castigli E, Wilson SA, Garibyan L, et al.: TACI is mutant in common variable Immunodeficiency and IgA Deficiency. Nat Genet 2005, 37:829–834. This article reports on five families of CVID/IGAD patients with TACI mutations.
Salzer U, Chapel HM, Webster AD, et al.: Mutations in TNFRSF13B encoding TACI are associated with common variable Immunodeficiency in humans. Nat Genet 2005, 37:820–828. This article reports on sporadic and familial CVID patients with TACI mutations.
Geha RS, Jabara HH, Brodeur SR: The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003, 3:721–732.
Litinskiy MB, Nardelli B, Hilbert DM, et al.: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822–829.
Ramesh N, Morio T, Fuleihan R, et al.: CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1). Clin Immunol Immunopathol 1995, 76:S208-S213.
Mackay F, Kalled SL: TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol 2002, 14:783–790.
MacLennan I, Vinuesa C: Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 2002, 17:235–238.
Gorelik L, Gilbride K, Dobles M: Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003, 198:937–945.
Schiemann B, Gommerman JL, Vora K, et al.: An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293:2111–2114.
Yan M, Wang H, Chan B, et al.: Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2001, 2:638–643.
Castigli E, Scott S, Dedeoglu F, et al.: Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A 2004, 101:3903–3908.
Von Bulow GU, Bram RJ: NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 1997, 278:138–1341.
Castigli E, Wilson SA, Scott S, et al.: TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005, 201:35–39.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rachid, R., Castigli, E., Geha, R.S. et al. TACI mutation in common variable immunodeficiency and IgA deficiency. Curr Allergy Asthma Rep 6, 357–362 (2006). https://doi.org/10.1007/s11882-996-0004-9
Issue Date:
DOI: https://doi.org/10.1007/s11882-996-0004-9